Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Nov 14, 2016 · 10-Q · 45 days after period end · 0001144204-16-134410
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$1.61M | -$2.60M | -$2.42M | -$1.08M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end
